Table 1.
Variable | Arm A: SC, % (n = 57) | Arm B: EPO, % (n = 53) | Total, % (n = 110) |
---|---|---|---|
Age ≥ 65 y | 88 | 81 | 85 |
Male sex | 63 | 62 | 63 |
MDS subtype | |||
RA | 39 | 38 | 38 |
RARS | 30 | 38 | 34 |
RAEB | 30 | 23 | 26 |
CMML | 2 | 1 | 2 |
Platelets < 100 000/cmm | 30 | 25 | 27 |
Ferritin > 500 ng/mL | 58 | 53 | 56 |
EPO < 200 mU/mL | 67 | 72 | 69 |
Cytogenetics* | |||
Good | 70 | 71 | 71 |
Intermediate | 16 | 15 | 15 |
Poor | 14 | 14 | 14 |
IPSS category | |||
Low/intermediate-1 | 84 | 83 | 83 |
Intermediate-2/high | 16 | 17 | 17 |
Prior transfusion support | 61 | 60 | 61 |
International Prognostic Scoring System risk category.2